Lv1
30 积分 2025-01-22 加入
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
4小时前
待确认
Androgen receptor activity in T cells limits checkpoint blockade efficacy
14天前
已完结
AR in immunotherapy
14天前
已完结
The changing therapeutic landscape of head and neck cancer
1个月前
已完结
Second-line treatment strategies for RAS wild-type colorectal cancer: A systematic review and Network Meta-analysis (NMA)
1个月前
已完结
Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm
1个月前
已完结
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
1个月前
已完结
Anti–Vascular Endothelial Growth Factor/Programmed Cell Death Protein 1 Bispecific Antibodies: Using Nunchucks to Fight an Old Adversary
3个月前
已完结
皖公网安备34019202002308
